The historical rank and industry rank for BRIM Biotechnology's OCF Margin % or its related term are showing as below:
TPE:6885'
s OCF Margin % Range Over the Past 10 Years
Min: -663207.78 Med: -31972.14 Max: -140.05
Current: -5995.83
During the past 7 years, the highest OCF Margin % of BRIM Biotechnology was -140.05%. The lowest was -663207.78%. And the median was -31972.14%.
TPE:6885's OCF Margin % is ranked worse than 92.31% of 949
companies
in the Biotechnology industry
Industry Median: -64.23
vs TPE:6885: -5995.83
BRIM Biotechnology OCF Margin % Related Terms
BRIM Biotechnology OCF Margin % Historical Data
* Premium members only.
The historical data trend for BRIM Biotechnology's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:6885 vs VRTX, REGN, ALNY: OCF Margin % Comparison
For the Biotechnology subindustry, BRIM Biotechnology's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BRIM Biotechnology OCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, BRIM Biotechnology's OCF Margin % distribution charts can be found below:
* The bar in red indicates where BRIM Biotechnology's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BRIM Biotechnology (TPE:6885) has a OCF Margin % of 7,916.44% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on BRIM Biotechnology and its competitors. According to the industry distribution chart, BRIM Biotechnology ranks #876 out of 949 companies in the Biotechnology industry, placing it in the top 92.3%.
Is BRIM Biotechnology's OCF Margin % too high?
BRIM Biotechnology's current OCF Margin % is 7,916.44%. Based on the distribution chart, BRIM Biotechnology ranks #876 out of 949 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, BRIM Biotechnology has a GF Score™ of 40/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BRIM Biotechnology's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BRIM Biotechnology ranks #876 out of 949 companies for OCF Margin %. This places BRIM Biotechnology in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on BRIM Biotechnology and its competitors. BRIM Biotechnology's current OCF Margin % is 7,916.44%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BRIM Biotechnology stock overvalued right now?
Based on GuruFocus' analysis, BRIM Biotechnology (TPE:6885) is currently considered Possible Value Trap. The stock's GF Value™ is NT$486.91, compared to a current price of NT$21.75 — trading 95.5% below its estimated fair value. The current OCF Margin % is 7,916.44%. BRIM Biotechnology's overall GF Score™ is 40/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For BRIM Biotechnology (TPE:6885), the current OCF Margin % is 7,916.44% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BRIM Biotechnology (TPE:6885) Overvalued in 2026?
Based on GuruFocus' analysis, BRIM Biotechnology stock appears to be undervalued.
The current stock price of NT$21.75 is trading 95.5% below its estimated GF Value™ of NT$486.91.
GuruFocus considers BRIM Biotechnology to be Possible Value Trap.
Key valuation signals for TPE:6885:
OCF Margin %: 7,916.44%
GF Value™: NT$486.91 vs. price of NT$21.75 (95.5% below fair value)
No single metric tells the full story. See the TPE:6885 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BRIM Biotechnology Inc is engaged in the research and development of new drug translation, genetic testing services, research and development services in natural and engineering sciences, and medical laboratory services. The Group has two reportable operating segments: BRIM's main business is new drug translational development services, and Compass's main business is gene sequencing and testing technology services. It generates the majority of its revenue from the BRIM segment. Geographically, it operates in Taiwan, Japan, and the USA. It generates the majority of its revenue from Taiwan.
40GF Score
Get the complete analysis for TPE:6885
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6885 has been successfully added to your 
